台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

NDP081: Prostatic and urinary bladder malakoplakia mimic bladder cancer: rare case report and literature review

2024-12-20 • 觀看: 468 • 回應: 0 • doc
NDP080: A Rare Giant Adrenal Myelolipoma in a Young Patient: Robotic Resection Case Report

2024-12-20 • 觀看: 551 • 回應: 0 • doc
NDP079: Recurrent B-Cell Lymphoma Mimicking a Solid Urinary Bladder Tumor: A Case Report

2024-12-20 • 觀看: 454 • 回應: 0 • doc
NDP078: Enfortumab vedotin plus Pembrolizumab as Neoadjuvant Therapy Before Parital Cystectomy in Muscle-Invasive Bladder Cancer: A Case Report

2024-12-20 • 觀看: 587 • 回應: 0 • doc
NDP077: Metachronous metastases of renal cell carcinoma to the thyroid and bladder - A case report

2024-12-20 • 觀看: 466 • 回應: 0 • doc
NDP076: A 25 cm length foreign body in bladder– a case report

2024-12-20 • 觀看: 503 • 回應: 0 • doc
5. The Experience of VGH Taipei in PSMA Radio-Ligand Therapy (PRLT) for mCRPC_林可瀚

2024-12-20 • 觀看: 1 • 回應: 0 • embed
4. The Impact of Bone Health on Prostate Cancer with Bone Metastasis: PEACE III Updates from ESMO_蔡昇翰

2024-12-20 • 觀看: 4 • 回應: 0 • embed
3. Why Ultra-Low PSA Matters: Clinical Benefits of Apalutamide plus ADT and Current Status of mCSPC in Japan_Prof. Shinichi Sakamoto

2024-12-20 • 觀看: 4 • 回應: 0 • embed
2. The Role of IO Agents on Peri-Operative Settings for Locally Advanced Muscle-Invasive UC_洪健華

2024-12-20 • 觀看: 4 • 回應: 0 • embed
1. Regarding advanced UC Regimens, Chemo-free, Chemo Plus Upfront or Switch Maintenance IO?_賴峻毅

2024-12-20 • 觀看: 5 • 回應: 0 • embed
NDP075: Large renal tumor inducing compression of the inferior vena cava: A case report

2024-12-20 • 觀看: 489 • 回應: 0 • doc

Prev
120
121
122
123
124
125
126
127
128
129
Next
/ 1134